Version 5.4
Bos taurus Protein: BLCAP
Summary
InnateDB Protein IDBP-695027.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BLCAP
Protein Name Bladder cancer-associated protein
Synonyms
Species Bos taurus
Ensembl Protein ENSBTAP00000004167
InnateDB Gene IDBG-642566 (BLCAP)
Protein Structure
UniProt Annotation
Function May regulate cell proliferation and coordinate apoptosis and cell cycle progression via a novel mechanism independent of both p53/TP53 and nuclear factor kappa B (NF-kappaB). {ECO:0000250}.
Subcellular Localization Membrane {ECO:0000305}; Multi-pass membrane protein {ECO:0000305}.
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
Predicted by orthology
Total 1 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0003674 molecular_function
GO:0005515 protein binding
Biological Process
GO:0006915 apoptotic process
GO:0007049 cell cycle
GO:0008150 biological_process
GO:0030262 apoptotic nuclear changes
Cellular Component
GO:0016020 membrane
GO:0016021 integral component of membrane
Protein Structure and Domains
PDB ID
InterPro IPR018015 Bladder cancer-related BC10-like
PFAM PF06726
PRINTS
PIRSF
SMART
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt P62954
PhosphoSite PhosphoSite-
TrEMBL
UniProt Splice Variant
Entrez Gene 281649
UniGene Bt.9020
RefSeq NP_776675
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL AB071597 BC118229 BT030495
GenPept AAI18230 ABQ12935 BAB68125

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca